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Primary heart tumours in the paediatric population are very rare and they range 
from 0.01% to 0.04%. Most are benign lesions of which about half are rhabdo-
myomas. Rhabdomyoma tumour diagnosis is associated with a 75–80% risk of 
tuberous sclerosis complex (TSC). TSC are characterised with numerous changes 
of hamartoma-type located in the brain, kidneys, skin and other organs including 
the heart. More than two-thirds of newborns with TSC present rhabdomyomas 
in the heart. These changes may be asymptomatic, but in some cases they may 
cause heart failure, arrhythmias and death. We present a case report of an infant 
with giant rhabdomyoma tumours in the course of TSC. (Folia Morphol 2018; 
77, 3: 601–603)
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INTRODUCTION
Primary cardiac tumours in the paediatric popula-
tion are very rare and occur with a frequency from 
0.01% to 0.04% [3, 10]. The overwhelming majority 
are benign and 45–58% of heart tumours in children 
are rhabdomyoma [1, 7]. Less common tumours in 
children are fibroma, angioma and teratoma [1]. 
Myxoma, the most common primary cardiac tumour 
in adults, is very rare in the paediatric population. 
The diagnosis of rhabdomyoma in a child is associ-
ated with 75–80% risk of tuberous sclerosis [2, 14]. 
Tuberous sclerosis complex (TSC) is a genetic disease 
first described by Bourneville, a French neurologist, 
in 1880. TSC is caused by mutations in the TSC1 gene 
(chromosome 9th) which code for Hamartin or TSC2 
gene (chromosome 16th) which code for Tuberine. 
It is characterised with numerous changes of hamar-
toma-type located in the brain, kidneys, skin and 
other organs and manifests itself with characteristic 
symptoms such as epilepsy, mental retardation, and 
skin lesions. Over two-thirds of infants with TSC pre-
sent rhabdomyoma in the heart [4]. Rhabdomyoma 
tumour is a major feature in the diagnosis of TSC [9]. 
Macroscopically, these are uniform, round tumours 
with a lighter shade than a healthy cardiac muscle. 
The microscopically pathogenic feature of rhabdo-
myoma is the presence of spider cells with centrally 
placed cytoplasm containing the nucleus and myofi-
brils radiating to the cell wall. Rhabdomyomas exhibit 
immunoreactivity with the muscle markers desmin, 
actin, myoglobin, vimentin, hamartin and tuberin. 
Immunohistochemical studies showed that the spider 
cells exhibit immunoreactivity with ubiquitin [15]. The 
changes are localised in 94% in the ventricles and 
may be clinically asymptomatic; however, in some 
cases they can lead to a heart failure, arrhythmias 
and death [6, 11]. Rhabdomyoma is a benign tu-
mour, with no tendency to infiltrate neighbouring 
structures. The possible location of the tumour is 
a cardiac conduction system, where by pressure on 
neighbouring tissues, the tumour may manifest clini-
cally as a conduction block and lead to death [12]. 
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A characteristic feature of rhabdomyoma is a tendency 
to involution and a total regression of changes until 
2 years of age is observed in 75–80% of affected 
children [5]. However, cardiological disorders are one 
of the leading causes of death in patients with TSC 
in the first decade of life. In symptomatic patients, 
the treatment option is a cardiac surgery; however, 
there is a high risk of mortality [5]. Over recent years, 
more than dozen case reports of tumour regression 
after the application of the mTOR inhibitor Everolimus 
have been published [8, 13].
We present a case of a child with giant heart 
tumours (rhabdomyoma) in the course of TSC. Ac-
cording to the best of our knowledge, these are one 
of the largest tumours described in the literature. 
CASE REPORT
The newborn with prenatally diagnosed (ultrasonog-
raphy and magnetic resonance imaging exams) multiple 
tumours of the heart and brain lesions characteristic of 
TSC underwent a cardiologic consultation immediately 
after the birth. The neonate was clinically asymptomatic.
Echocardiography revealed normal ejection frac-
tion and left ventricular size (LVIDd 17 mm) and con-
firmed the presence of multiple cardiac tumours, the 
largest in the apex of the dimensions of 33 × 30 mm, 
two smaller in the interventricular septum with di-
mensions of 14 × 11 mm and 9 × 5 mm and a few 
small ones in the free wall of right and left ventricle 
(Figs. 1, 2). There was no evidence of obstruction of 
both the inflow and the outflow track of the heart. 
Figure 1. Modified 5-chamber view; Ao — aorta; LV — left  
ventricle; RV — right ventricle.
Figure 2. Parasternal short axis view; LV — left ventricle.
Figure 3. Regular sinus rhythm 143/min. Normal axis deviation. Normal SA and AV conduction. QRS 70 ms, no signs of intraventricular  
conduction disturbances. In lead V1 Rsr’ QRS morphology. No signs of atrial or ventricular hypertrophy. ST segment depression > 1 mm  
and T wave changes: positive/negative in leads II, III, aVF and V1–V3. In leads V3–V6 positive J point deflection (1–3 mm) with evident 
domed ST-segment elevation. QT 260 ms (not corrected).
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The right ventricle pressure was increased up to 
70 mmHg, measured from the tricuspid regurgitation. 
Several electrocardiogram (ECG) examinations 
showed generalised repolarisation abnormalities 
(Fig. 3). There were no arrhythmias on the 24 h 
Holter-ECG monitoring and on telemonitoring. The 
laboratory tests revealed normal level of B-type natriu-
retic peptide and the troponin level increased up to 22× 
upper limit of hospital laboratory reference range 
for adults. Because of the normal global ejection 
fraction and the lack of therapeutic options at that 
time, the coronary angiography was not performed. 
The normalisation of levels of troponin at 8 weeks of 
age was documented.
During the 3 months of follow-up the elevated 
pressure in the right ventricle was present in echocar-
diographic exams. Because of this, the chest angio-
computed tomography was performed (Fig. 4) and 
it showed no obstructions in the runoff from the 
pulmonary veins to the left atrium. In the subsequent 
echocardiographic studies the normalisation of the 
pressure in the right ventricle was observed. Dur-
ing half year of the follow-up, the child remained 
asymptomatic.
CONCLUSIONS
An asymptomatic neonate with multiple huge 
cardiac tumours requires a close follow-up with serial 
imaging and electrocardiography because of the risk 
of a sudden and unsuspected death in this group of 
patients. A spontaneous resolution of the rhabdo-
myomas may occur in children with the confirmed 
diagnosis of tuberous sclerosis. 
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Figure 4. Computed tomography angiography of the chest.
